The British government announced Friday it has a deal for 90 million doses of COVID-19 vaccines now under development at
The "agreement in principal" includes 60 million doses of the
"Today's agreements will not only benefit people in the
The deal agrees to fund a large-scale clinical trial of the Janssen vaccine candidate later this year. Its primary endpoint will be to determine if two doses will provide long-term protection against the novel coronavirus that causes COVID-19.
In return, the vaccine, if proven effective, will be made available worldwide on a not-for-profit basis.
A stage-three trial for
"Our Phase 3 clinical trial in the
With the new agreements, the British government said it has access to six different candidates for its portfolio of potential COVID-19 vaccines and hopes one or more will be safe and effective.
A number of potential coronavirus vaccines are now in various stages of development. Click here for our COVID-19 vaccine tracker.
Copyright 2020 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent., source